Irbesartan
- Product NDC
- 50268-441
- 11-digit product format
- 502680441
- Labeler code
- 50268
- Product ID
- 50268-441_3c1c8771-3bbc-7b5a-e063-6394a90a192c
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Irbesartan
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- AvPAK
- Application
- ANDA202910
- Marketing category
- ANDA
- Marketing start
- 2023-08-08
- Substance
- IRBESARTAN
- Active strength
- 150 mg/1
- Pharmacologic classes
- Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Irbesartan
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| IRBESARTAN | 150 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | J0E2756Z7N |
| Rxcui | 200094, 200095, 200096 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 50268-441-11 | Irbesartan | 1 in 1 BLISTER PACK | TABLET | 1 | | 9 |
| 50268-441-15 | Irbesartan | 50 in 1 BOX, UNIT-DOSE | TABLET | 50 | | 9 |
DailyMed Socrata Ingredients#
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 50268-441 | IRBESARTAN TABLET [AVPAK] | 8 | Current NDC, Legacy NDC, 2 package rows | 20250112_61b60f94-35e6-b90b-08ce-fbb2fe011f34.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 50268-441-11 | 50268044111 | 1 in 1 BLISTER PACK | | | | | Historical |
| 50268-441-15 | 50268044115 | 50 BLISTER PACK in 1 BOX, UNIT-DOSE (50268-441-15) / 1 TABLET in 1 BLISTER PACK (50268-441-11) | 50 blister pack | 2023-08-08 | No | No | Current |